The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study-Reference-Cited by-同舟云学术

The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study

Published:2022-06-29 Issue:3 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Xin Henan¹,Cao Xuefang¹,Du Ying¹,Yan Jiaoxia²,He Rui³,Liu Zisen²,Zhang Haoran¹,He Yijun¹,Zhang Bin²,Wang Dakuan²,Guan Ling³,Shen Fei³,Feng Boxuan¹,Quan Zhusheng¹,He Yongpeng¹,Liu Jianmin³,Jin Qi¹,Pan Shouguo²,Gao Lei¹^ORCID

Affiliation:

1. NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

2. Center for Diseases Control and Prevention of Zhongmu, Zhengzhou, People’s Republic of China

3. Sixth People’s Hospital of Zhengzhou, Zhengzhou, People’s Republic of China

Abstract

Approximately a quarter of the world population are infected with M. tuberculosis and about 5% to 10% of these might develop active disease in their lifetime. Preventive treatment could effectively protect individuals at a high risk of developing active disease from LTBI, and is regarded as a critical component of End TB Strategies.

Funder

CAMS Innovation Fund For Medical Sciences

National Natural Science Foundation of China

National Science and Technology Major Project

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02625-21

Reference28 articles.

1. WHO. 2020. Global tuberculosis report 2020. WHO Geneva Switzerland. Available from: https://apps.who.int/iris/handle/10665/336069?locale-attribute=en&. Accessed 24 December 2020.

2. WHO. 2020. WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Tuberculosis preventive treatment. WHO Geneva Switzerland. Available from: https://www.who.int/publications-detail/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment. Accessed 24 March 2020.

3. MicroRNAs as regulatory elements in immune system logic

4. Fine‐tuning of the innate immune response by microRNAs

5. Micromanagement of the immune system by microRNAs

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine;Frontiers in Microbiology;2023-10-04

2. MicroRNAs as immune regulators and biomarkers in tuberculosis;Frontiers in Immunology;2022-10-27

3. Immune regulation and emerging roles of noncoding RNAs in Mycobacterium tuberculosis infection;Frontiers in Immunology;2022-10-13